These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 23046320
1. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. Fanelli F, Cannavale A, Boatta E, Corona M, Lucatelli P, Wlderk A, Cirelli C, Salvatori FM. J Endovasc Ther; 2012 Oct; 19(5):571-80. PubMed ID: 23046320 [Abstract] [Full Text] [Related]
2. The "DEBELLUM"--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results. Fanelli F, Cannavale A, Corona M, Lucatelli P, Wlderk A, Salvatori FM. J Cardiovasc Surg (Torino); 2014 Apr; 55(2):207-16. PubMed ID: 24670828 [Abstract] [Full Text] [Related]
3. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203 [Abstract] [Full Text] [Related]
7. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Kayssi A, Al-Jundi W, Papia G, Kucey DS, Forbes T, Rajan DK, Neville R, Dueck AD. Cochrane Database Syst Rev; 2019 Jan 26; 1(1):CD012510. PubMed ID: 30684445 [Abstract] [Full Text] [Related]
8. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Karimi A, de Boer SW, van den Heuvel DA, Fioole B, Vroegindeweij D, Heyligers JM, Lohle PN, Elgersma O, Nolthenius RP, Vos JA, de Vries JP. Trials; 2013 Mar 28; 14():87. PubMed ID: 23537403 [Abstract] [Full Text] [Related]
9. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Kayssi A, Al-Atassi T, Oreopoulos G, Roche-Nagle G, Tan KT, Rajan DK. Cochrane Database Syst Rev; 2016 Aug 04; 2016(8):CD011319. PubMed ID: 27490003 [Abstract] [Full Text] [Related]
10. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F. JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828 [Abstract] [Full Text] [Related]
11. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial. Jongsma H, van Mierlo-van den Broek P, Imani F, van den Heuvel D, de Vries JPM, Fioole B. J Vasc Surg; 2017 Oct 11; 66(4):1293-1298. PubMed ID: 28826727 [Abstract] [Full Text] [Related]
12. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study. Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. J Endovasc Ther; 2016 Feb 11; 23(1):52-7. PubMed ID: 26511896 [Abstract] [Full Text] [Related]
16. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, Scheinert D, Schulte KL, Rastan A, Brodmann M. JACC Cardiovasc Interv; 2015 Oct 11; 8(12):1614-22. PubMed ID: 26493253 [Abstract] [Full Text] [Related]
17. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study. Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A. JACC Cardiovasc Interv; 2016 May 09; 9(9):950-6. PubMed ID: 27151609 [Abstract] [Full Text] [Related]
19. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study. Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators. Vascular; 2021 Jun 09; 29(3):340-349. PubMed ID: 32903168 [Abstract] [Full Text] [Related]
20. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, Siablis D. J Endovasc Ther; 2011 Feb 09; 18(1):1-12. PubMed ID: 21314342 [Abstract] [Full Text] [Related] Page: [Next] [New Search]